Fact CheckerSign in

NCT07203157Active, not recruiting

HEAL-SLE: Holistic Energy for Alleviating Lupus Symptoms

A Pilot Study Evaluating the Effect and Feasibility of Virtual Reiki Therapy as a Complementary Treatment for Patients With Systemic Lupus Erythematosus

Source: ClinicalTrials.gov · Last updated 12 Aug 2026

Brief summary (registry, in English)

The purpose of this study is to assess the efficacy, feasibility, and acceptability of Virtual Reiki therapy as a complementary treatment for patients with systemic lupus erythematosus (SLE). The study also aims to investigate the feasibility, acceptability, and adherence of integrating Virtual Reiki therapy within the healthcare system for patients with SLE. Participants receiving standard of care (SOC) treatment for SLE will continue SOC while receiving research-specific Virtual Reiki therapy once per week for 8 weeks. Each study session will be delivered remotely by a Certified Reiki Practitioner Level II or higher.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
20 (actual)
First submitted
24 Sept 2025
Start date
3 Mar 2026
Primary completion date
31 Oct 2026
Lead sponsor
NYU Langone Health
Diseases
Lupus (SLE)
NCT number
NCT07203157

What you commit to

  • Study type: Interventional
  • Participants enrolled: 20
  • From 3 Mar 2026 to the primary completion date, 31 Oct 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients experiencing severe disease activity requiring hospitalization at time of screening

Age

  • Under 18 years of age

Other

  • Unable to read, speak and understand English
  • No access to internet
  • Not willing to participate in weekly virtual Reiki sessions
  • Currently enrolled in another interventional clinical trial

Who the study is looking for

  • Adult aged 18 and older at the time of informed consent
  • Diagnosed with SLE (based on 2019 American College of Rheumatology (ACR)/ European League Against Rheumatism (EULAR) criteria)
  • Currently receiving SOC treatment for SLE at NYU Langone Orthopedic Center
  • Able and willing to provide consent and participate in 8 weekly virtual Reiki sessions
  • Has access to reliable internet, have an active email address, and able to utilize WebEx
  • Able to read, speak and understand English

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
NYU Langone Health
Coordinator of this site? Confirm its status
New YorkUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.